48
Views
6
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Stent‐based percutaneous coronary interventions in small coronary arteries

&
Pages 70-74 | Accepted 10 Apr 2006, Published online: 10 Jul 2009

References

  • Macaya C., Serruys P. W., Ruygrok P., et al. Continued benefit of coronary stenting versus balloon angioplasty: One‐year clinical follow‐up of BENESTENT trial. J Am Coll Cardiol 1996; 27: 255–61
  • Leon M. B., Baim D. S., Popma J. J., et al. A clinical trial comparing three antithrombotic‐drug regimens after coronary‐artery stenting: Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998; 339: 1665–71
  • Schunkert H., Harrell L., Palacios I. F. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization. J Am Coll Cardiol 1999; 34: 40–8
  • de Feyter P. J., Kay P., Disco C., Serruys P. W. Reference chart derived from post‐stent implantation intravascular ultrasound predictors of 6‐month expected restenosis on quantitative coronary angiography. Circulation 1999; 100: 1777–83
  • Kastrati A., Dirschinger J., Boekstegers P., et al. Influence of stent design on 1‐year outcome after coronary stent placement: A randomized comparison of five stent types in 1,147 unselected patients. Cathet Cardiovasc Intervent 2000; 50: 290–7
  • Lansky A. J., Roubin G. S., O'Shaughnessy C. D., et al. Randomized comparison of GR‐II stent and Palmaz‐Schatz stent for elective treatment of coronary stenoses. Circulation 2000; 102: 1364–8
  • Kastrati A., Schömig A., Dirschinger J., et al. Increased risk of restenosis after placement of gold‐coated stents: Results of a randomized trial comparing gold‐coated with uncoated steel stents in patients with coronary artery disease. Circulation 2000; 101: 2478–83
  • Kastrati A., Mehilli J., Dirschinger J., et al. Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on REstenosis Outcome (ISAR‐STEREO) trial. Circulation 2001; 103: 2816–21
  • Casella G., Prati F., on behalf of the Multi‐Link Pixel Multicenter Italian Registry. Stenting small coronary arteries: Multi‐link Pixel multicenter Italian registry. J Invas Cardiol 2003; 15: 371–6
  • Kastrati A., Schömig A., Dirschinger J., et al. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. Circulation 2000; 102: 2593–8
  • Koning R., Eltchaninoff H., Commeau P., et al. Stent placement compared with balloon angioplasty for small coronary arteries: In‐hospital and 6‐month clinical and angiographic results (BESMART). Circulation 2001; 104: 1604–1608
  • Rodriguez A., Rodriguez Alemparte M., Fernandez Pereira C., Sampaolesi A., da Rocha Loures Bueno R., et al. LASMAL investigators. Latin American randomized trial of balloon angioplasty vs coronary stenting for small vessels (LASMAL): immediate and long‐term results. Am J Med 2005; 118: 743–51
  • Moer R., Myreng Y., Mølstad P., et al. Stenting In Small Coronary Arteries (SISCA): A randomized comparison of balloon angioplasty and the heparin‐coated BeStent. J Am Coll Cardiol 2001; 38: 1598–603
  • Doucet S., Schalij M. J., Vrolix M. C. M., et al. for the Stent In Small Arteries (SISA) Trial. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 2001; 104: 2029–33
  • Park S. W., Lee C. W., Hong M. K., et al. Randomized comparison of coronary stenting with optimal balloon angioplasty for treatment of lesions in small coronary arteries. Eur Heart J 2000; 21: 1785–9
  • Savage M. P., Fischman D. L., Kada F., et al. A randomized comparison of elective stenting and balloon angioplasty in the treatment of small coronary arteries (Abstr). Circulation 1999; 100((Suppl I))I503
  • Haude M., Konorza T. F. M., Kalnins U., et al. Heparin‐coated stent placement for the treatment of stenoses in small coronary arteries of symptomatic patients. Circulation 2003; 107: 1265–70
  • Kastrati A., Schhlen H., Schömig A. Stenting for small coronary vessels: A contestable winner. J Am Coll Cardiol 2001; 38: 1604–7
  • Hehrlein C., Zimmermann M., Metz J., et al. Influence of surface texture and charge on the biocompatibility of endovascular stents. Coron Artery Dis 1995; 6: 581–6
  • Edelman E. R., Seifert P., Groothuis A., et al. Gold‐coated NIR stents in porcine coronary arteries. Circulation 2001; 103: 429–34
  • Moses J. W., Buller C. E. H., Nukta E. D., et al. The first clinical trial comparing a coated versus a noncoated coronary stent: The Biocompatibles BiodivYsio stent in randomized control trial (DISTINCT) (Abstr). Circulation 2000; 101((Suppl II))664
  • Hausleiter J., Kastrati A., Mehilli J., et al. A randomized trial comparing phosphorylcholine‐coated stents with balloon angioplasty in small coronary arteries in patients with symptomatic coronary artery disease. The ISAR‐SMART 2 trial (Abstr). Circulation 2003; 108((Suppl IV))569
  • Wohrle J., Al‐Khayer U., Grotzinger C., et al. Comparison of the heparin‐coated versus the uncoated Jostent ‐ No influence of restenosis or clinical outcome. Eur Heart J 2001; 22: 1808–16
  • Morice M. C., Serruys P. W., Sousa J. E., et al. for the RAVEL study group. A randomized comparison of a sirolimus‐eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773–80
  • Moses J. W., Leon M. B., Popma J. J., et al. for the SIRIUS Investigators. Sirolimus‐eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315–23
  • Schofer J., SchlFCter M., Gershlick A. H., et al. for the E‐SIRIUS Investigators. Sirolimus‐eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: Double‐blind, randomised controlled trial (E‐SIRIUS). Lancet 2003; 362: 1093–9
  • Schampaert E., Cohen E. A., Schluter M., et al. The Canadian study of the sirolimus‐eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C‐SIRIUS). J Am Coll Cardiol 2004; 43: 1110–5
  • Stone G. W., Ellis S. G., Cox D. A., Hermiller J., O'Shaughnessy C., Mann J. T., et al. TAXUS‐IV Investigators. One‐year clinical results with the slow‐release, polymer‐based, paclitaxel‐eluting TAXUS stent: the TAXUS‐IV trial. Circulation 2004; 109: 1942–7
  • Gershlick A. H., De Scheerder I., Chevalier B., et al. Inhibition of restenosis with a paclitaxel‐eluting polymer‐free coronary stent. The European Evaluation of Paclitaxel‐Eluting Stent (ELUTES) trial. Circulation 2004; 109: 487–93
  • Lansky A. J., Costa R. A., Mintz G. S., Tsuchiya Y., Midei M., Cox D. A., et al. DELIVER Clinical Trial Investigators. Non‐polymer‐based paclitaxel‐coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow‐up of the DELIVER clinical trial. Circulation 2004; 109: 1948–54
  • Meier B., Sousa E., Guagliumi G., et al. Sirolimus‐eluting coronary stents in small vessels. Am Heart J. 2006; 151: 1026.e1–7
  • Ardissino D., Cavallini C., Bramucci E., Indolfi C., Marzocchi A., Manari A., et al. SES‐SMART Investigators. Sirolimus‐eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 2004; 292: 2727–34
  • Mehilli J., Dibra A., Kastrati A., Pache J., Dirschinger J., Schomig A. Randomized trial of paclitaxel‐ and sirolimus‐eluting stents in small coronary vessels. Eur Heart J 2006; 27: 260–6. Epub Jan 9 2006

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.